Teleflex Net Acquisitions/Divestitures 2010-2025 | TFX
Teleflex annual/quarterly net acquisitions/divestitures history and growth rate from 2010 to 2025. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
- Teleflex net acquisitions/divestitures for the quarter ending March 31, 2025 were $0.000B, a 28.57% increase year-over-year.
- Teleflex net acquisitions/divestitures for the twelve months ending March 31, 2025 were $0.000B, a 99.93% decline year-over-year.
- Teleflex annual net acquisitions/divestitures for 2024 were $-0B, a 99.98% decline from 2023.
- Teleflex annual net acquisitions/divestitures for 2023 were $-0.589B, a 216.63% increase from 2022.
- Teleflex annual net acquisitions/divestitures for 2022 were $-0.186B, a 184.42% decline from 2021.
| Teleflex Annual Net Acquisitions/Divestitures (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $-589 |
| 2022 | $-186 |
| 2021 | $220 |
| 2020 | $-766 |
| 2019 | $-3 |
| 2018 | $-117 |
| 2017 | $-1,762 |
| 2016 | $-4 |
| 2015 | $-93 |
| 2014 | $-41 |
| 2013 | $-309 |
| 2012 | $-303 |
| 2011 | $351 |
| 2010 | $181 |
| 2009 | $314 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.603B | $3.047B |
| Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.130B | 88.53 |
| Thermo Fisher Scientific (TMO) | United States | $161.926B | 19.59 |
| Alcon (ALC) | Switzerland | $45.995B | 31.08 |
| Edwards Lifesciences (EW) | United States | $44.288B | 29.04 |
| IDEXX Laboratories (IDXX) | United States | $40.945B | 47.06 |
| DexCom (DXCM) | United States | $32.980B | 50.98 |
| IQVIA Holdings (IQV) | United States | $26.068B | 14.60 |
| Mettler-Toledo (MTD) | United States | $24.462B | 29.09 |
| STERIS (STE) | Ireland | $22.711B | 25.97 |
| Waters (WAT) | United States | $21.365B | 30.14 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.057B | 0.00 |
| Hologic (HOLX) | United States | $12.729B | 13.83 |
| Sysmex ADR (SSMXY) | Japan | $11.601B | 0.00 |
| Penumbra (PEN) | United States | $11.465B | 89.99 |
| Masimo (MASI) | United States | $8.760B | 32.31 |
| Globus Medical (GMED) | United States | $8.012B | 18.79 |
| Glaukos (GKOS) | United States | $5.278B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.130B | 89.79 |
| PROCEPT BioRobotics (PRCT) | United States | $2.935B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.402B | 14.31 |
| Veracyte (VCYT) | United States | $2.295B | 32.21 |
| Nihon Kohden (NHNKY) | Japan | $2.030B | 23.28 |
| Elekta AB (EKTAY) | Sweden | $2.018B | 18.14 |
| Alphatec Holdings (ATEC) | United States | $1.859B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.541B | 0.00 |
| Artivion (AORT) | United States | $1.235B | 115.64 |
| Pulse Biosciences (PLSE) | United States | $1.133B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.050B | 5.58 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| SiBone (SIBN) | United States | $0.792B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.690B | 15.08 |
| IRadimed (IRMD) | United States | $0.677B | 34.34 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.588B | 9.14 |
| Beta Bionics (BBNX) | United States | $0.572B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.564B | 0.00 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.532B | 0.00 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.352B | 10.89 |
| Pacific Biosciences Of California (PACB) | United States | $0.345B | 0.00 |
| Neuronetics (STIM) | United States | $0.293B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.230B | 13.91 |
| Alpha Tau Medical (DRTS) | Israel | $0.194B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| 908 Devices (MASS) | United States | $0.166B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.164B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| CVRx (CVRX) | United States | $0.142B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.083B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 11.48 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.061B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.25 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.00 |